Long COVID fatigue and brain fog, somewhat better on luvox
- Condition
- Long COVID
- At worst
- Not stated
- Ill before improving or writing
- 15 months
- Last post
- Jul 2025
In their words
- Condition: Long COVID
yes, developed after my first covid case in summer of 22, diagnosed in late fall of the same year
In context ↗ - Now: Somewhat better
that, the H1/H2 antihistamine stack, and LDN has been the most successful treatment regimen for me
In context ↗ - Began after: COVID
yes, developed after my first covid case in summer of 22
Summary
They developed long COVID after a first COVID-19 infection in summer 2022 and were diagnosed that autumn. In a double-blind trial at a St. Louis long COVID clinic in autumn 2023 they received the SSRI luvox, which made a huge difference; missing a day brings back debilitating fatigue and brain fog. An H1/H2 antihistamine stack and LDN also helped, though terrible flares continued into 2025.
Ask Miruvor AI
What they tried
What they credit
Also tried
Their words about each treatment
- luvox · Helped a lot
i was part of a double blind study that tested the SSRI luvox as a treatment. i clearly got the medication, and it made a HUGE difference
In context ↗ - H1/H2 antihistamine stack · Helped
that, the H1/H2 antihistamine stack, and LDN has been the most successful treatment regimen for me
In context ↗ - microdose (substance not named) · Helped
when i have my worst days, i microdose, and it pulls me out of my most terrible flares
In context ↗
Approaches: H1 antihistamines · H2 blockers · SSRIs
Their path
They say too little about how ill they were at each step to draw it on the severity scale, so the steps are listed as they describe them. Dates are when they posted.
| When | What happened | After |
|---|---|---|
| summer of 22 | Long COVID developed after first COVID-19 case; diagnosed in late falldeveloped after my first covid case in summer of 22, diagnosed in late fall of the same yearIn context ↗ | |
| fall of 23 | Took part in SSRI luvox trial at Washington University long COVID clinic and got the drugi was part of a double blind study that tested the SSRI luvox as a treatment. i clearly got the medication, and it made a HUGE differenceIn context ↗ | Fluvoxamine (Luvox) |
| 2025-07-30 | Still has terrible flares on worst days; microdoses to pull out of themwhen i have my worst days, i microdose, and it pulls me out of my most terrible flaresIn context ↗ |
Symptoms mentioned
Their words about their symptoms
- Brain fog
if i miss a day, the fatigue and brain fog come back at such a debilitating level
In context ↗
Ask Miruvor AI
Similar stories
-
Housebound with long COVID, now much better and back at work after ketotifen and LDN
After COVID in 2021 at age 23, he had gut problems plus debilitating brain fog and sexual symptoms that faded over about two years. A new infection in 2025 left him housebound for three months and off work with air hunger, blurry vision, loss of sweating and…
-
Bedbound at worst with ME/CFS, now walking up to 8,000 steps, credits low-dose naltrexone
After a February 2024 viral infection, she was bedbound for about two months and during a crash could not move at all except to use the toilet. She credits low-dose naltrexone for gradual improvement; by November 2024 she was walking up to 8,000 steps, still…
-
Bedbound with long COVID for three months, now much better after a supplement protocol and time
Pebble 74580 got COVID in 2021 and long COVID began a few weeks later; he was bedbound for about three months. He reports a supplement protocol helped him climb out of the crash, Paxlovid temporarily wiped out symptoms, and time has been a major factor;…
-
Bedridden for four months with long COVID, now nearly back to normal after activity and rest
A 32-year-old in Japan caught COVID in July 2022 and spent about four months bedridden, unable to eat, and hospitalised for intravenous nutrition. Recovery began around month four, progressing at about 0.1-1% a day, which they credit to gradually increasing…